Description
Mvasi is a medication being studied in clinical trials. It is being investigated for use in certain types of cancer. In colorectal cancer trials, Mvasi has been studied in combination with other cancer drugs. The trials often include patients whose tumors have a specific genetic change called a KRAS mutation. The goal of these trials is to see how safe Mvasi is when given with other treatments and if it shows any signs of effectiveness in shrinking tumors or slowing cancer growth. Mvasi is not yet approved for treating colorectal cancer.
Mechanism of Action
The specific way Mvasi works (its mechanism of action) is being studied in clinical trials. It is being investigated as a potential treatment for cancers with specific genetic mutations, like KRAS p.G12C. The trials aim to understand how Mvasi affects cancer cells and whether it can be effective in combination with other therapies.
Side Effects
Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.